Health Care

Nanox Imaging CFO receives $50k RSU grant, signaling board confidence amid product and regulatory milestones, with modest dilution but strong investor buzz.

CEO Buell’s latest buy of 23,191 MINK shares shows insider confidence in the company’s iNKT therapy pipeline, signaling potential upside amid a volatile market.

Beyond Air insiders are buying big—over 21k shares—despite a 95% YTD drop, signaling confidence that a turnaround could lift the stock. Click to learn why.

Explore why Cook Meredith’s Rule 10b5‑1 sales are steady, not panic‑driven, and what that means for ANI Pharma’s outlook amid a weak stock trend.

Insider buying by ONEMEDNET’s CMO boosts optimism; fresh share purchase signals confidence amid a 85% price dip.

Opaleye Management’s recent steady buying of Grace Therapeutics shares shows confidence in its orphan‑drug pipeline, hinting at potential upside without market panic.

Insider moves at MYOMO reveal disciplined RSU‑driven equity strategy, aligning management with long‑term patient‑mobility goals.

Cadrenal CEO’s new 200k stock‑option buy hints at long‑term confidence amid recent heavy sell‑offs; investors should watch upcoming clinical milestones.

Inside Hinge Health’s CFO sell‑plan reveals steady confidence amid a 6.9% weekly rally—insider selling is routine, not a warning.

Elevance Health insider Lynn buys 2,283 shares at zero cost, boosting his stake to 84,156 shares—signaling confidence amid rising analyst targets and a 6.3% weekly gain.